Key result
Higher platelet count linked to ~5% lower odds of CHF per 10×10³/µL in CKD.
Why the study?
The association between platelet count and congestive heart failure in patients with chronic kidney disease was not well established.
Is a higher platelet count associated with lower odds of congestive heart failure in US adults with chronic kidney disease?
Cross-Sectional (n=2,540)
Yes
Is a higher platelet count associated with lower odds of congestive heart failure in US adults with chronic kidney disease?
In a nationally representative cross-sectional analysis of US adults with chronic kidney disease, higher platelet counts were independently and linearly associated with lower odds of self-reported congestive heart failure.
Answers are grounded in this paper and cite their sources.
Higher platelet count was associated with lower CHF odds in CKD; hypothesis-generating and should not yet change practice or risk models.
BACKGROUND: The primary objective of this study was to examine the association between platelet count (PLT) and congestive heart failure (CHF) in patients with chronic kidney disease (CKD). METHODS: Data from the National Health and Nutrition Examination Survey (NHANES, 2007-2018) were used to investigate the association between PLT and CHF in patients with CKD. Demographics, laboratory, and comorbidities data were analyzed. Multivariable logistic regression, stratified analysis, curve fitting, and subgroup analyses were performed to assess the association between PLT and CHF. RESULTS: A total of 2,540 participants were included, comprising 230 with CHF and 2,310 without CHF. In multivariable logistic regression analysis, after adjusting for various confounders across three models, PLT was inversely associated with CHF. Each 10×10³/µL increase in PLT was associated with lower odds of CHF in the crude model (OR 0.918, 95% CI: 0.897-0.940). The PLT-CHF relationship followed a linear trend (P for non-linearity = 0.567). Subgroup analysis revealed a significant interaction between female sex and CHF risk (P for interaction < 0.05). CONCLUSION: PLT was independently associated with CHF in patients with CKD. Each 10×10³/µL increment in PLT corresponded to lower odds of CHF in Model III.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) conducted a cross-sectional in Chronic kidney disease (CKD) and congestive heart failure (CHF) (n=2,540). Platelet count (PLT, per 10 × 10³/µL increment) vs. Lower platelet count (continuous per 10 × 10³/µL or lowest tertile T1 reference) was evaluated on Prevalence of self-reported physician-diagnosed congestive heart failure (CHF) (OR 0.947, 95% CI 0.918-0.976, p=<0.001). Each 10×10³/µL increase in platelet count was independently associated with lower odds of congestive heart failure in patients with chronic kidney disease.
Synapse has enriched 10 related papers. Consider them for comparative context: